September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Ocular Coherence Tomographic Imaging in Patients with Recurrent Full Thickness Macular Holes
Author Affiliations & Notes
  • Eli Levitt
    Eye, Beth Israel Deaconess Medical Center, Coral Gables, Florida, United States
  • Gina Yu
    Eye, Beth Israel Deaconess Medical Center, Coral Gables, Florida, United States
  • Aria Bassiri
    Eye, Beth Israel Deaconess Medical Center, Coral Gables, Florida, United States
  • Jorge G Arroyo
    Eye, Beth Israel Deaconess Medical Center, Coral Gables, Florida, United States
  • Footnotes
    Commercial Relationships   Eli Levitt, None; Gina Yu, None; Aria Bassiri, None; Jorge Arroyo, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4254. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Eli Levitt, Gina Yu, Aria Bassiri, Jorge G Arroyo; Ocular Coherence Tomographic Imaging in Patients with Recurrent Full Thickness Macular Holes
      . Invest. Ophthalmol. Vis. Sci. 2016;57(12):4254.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the efficacy of pars plana revision vitrectomy, ILM peeling, and long-term internal tamponade for recurrent full thickness macular holes (FTMH). The success rate of macular hole surgery in patients with a primary idiopathic macular holes ranges from 90-95%. Our study investigates the anatomic closure rate and the anatomic changes in macular holes, as visualized by ocular coherence tomography scanning, that occur in treatment of recurrent FTMHs.

Methods : This single-site, single-surgeon, retrospective study analyzed 12 medical records (13 eyes) of patients who received two surgeries at the Beth Israel Deaconess Medical Center for persistent macular holes (2004-2013). Persistent was defined as no closure (n=2 eyes) or reopening (n=11) at least 1 month following surgery. Patients were treated with a three-port, pars plana vitrectomy (PPV), with or without internal limiting and/or epiretinal membrane peeling, and fluid gas exchange of SF6 (n=2) or C3F8 (n=1), or silicone oil (n=10). The primary outcome measure was complete FTMH closure as established by ocular coherence tomography (OCT) within 1 month of the second procedure. Visual acuity was also documented pre- and post-reoperation. Any complications resulting from the second surgery and underlying eye conditions prior to receiving treatment were documented

Results : Ten out of 13 (76.9%) total eyes had closed FTMH 1 month following the second procedure, 1 out of 2 (50%) with an unclosed FTMH and 9 out of 11 with a reopened FTMH (90.1%). Six out of 10 patients (60%) in which VA was documented had improvement of at least 3 lines following surgery (1 week post-op), 2 (20%) remained the same, and 2 (20%) worsened.

Conclusions : We find that second PPV/MP in patients with persistent FTMH has high efficacy, though not as high as in primary macular hole surgery. Future larger studies are needed to validate these results.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×